Hard end-points for GH replacement therapy: Report from an interactive discussion of bone status and cardiovascular function in GH-deficient adults

被引:0
|
作者
Jorgensen, JOI [1 ]
机构
[1] Aarhus Univ Hosp, Med Dept Endocrinol & Metab M, DK-8000 Aarhus, Denmark
关键词
D O I
10.1016/S1096-6374(98)80012-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To stimulate debate and promote interaction between the audience and speakers, an interactive session entitled "Controversies in GH Replacement Therapy" was held at the 4th International hGH Symposium on GH Deficiency in Adults in September 1997 in Copenhagen, Denmark. The audience was asked to vote "yes" or "no" to a number of questions pertaining to the effects of growth hormone (GH) substitution in GH deficiency in adults on bone and cardiovascular function, respectively. This was followed by "pro" and "con" presentations on GH after which the audience gave their second and final vote (answer) to the initial questions. The designated "pro" and "con" speakers were selected on the basis of their scientific contributions within the relevant field rather than their personal beliefs. This is a report of the interactive session. (C) 1998 Churchill Livingstone.
引用
收藏
页码:63 / 67
页数:5
相关论文
共 29 条
  • [1] GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults
    Lanzi, R
    Losa, M
    Villa, I
    Gatti, E
    Sirtori, M
    Dal Fiume, C
    Rubinacci, A
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 (02) : 185 - 191
  • [2] Effect of growth hormone (GH) therapy on endothelial function in GH-deficient adults
    Pfeifer, M
    Poredos, P
    Zizek, B
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12): : 4923 - 4923
  • [3] Effect of growth hormone (GH) therapy on endothelial function in GH-deficient adults
    Smith, JC
    Evans, LM
    Davies, JS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (12): : 4749 - 4750
  • [4] Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults
    Svensson, J
    Fowelin, J
    Landin, K
    Bengtsson, BÅ
    Johansson, JO
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05): : 2121 - 2127
  • [5] The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults
    Bengtsson, BÅ
    Abs, R
    Bennmarker, H
    Monson, JP
    Feldt-Rasmussen, U
    Hernberg-Ståhl, E
    Westberg, B
    Wilton, P
    Wüster, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11): : 3929 - 3935
  • [6] Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: A preliminary report
    Bohdanowicz-Pawlak, A
    Szymczak, J
    Bladowska, J
    Bednarek-Tupikowska, G
    Bidzinska, B
    Milewicz, A
    MEDICAL SCIENCE MONITOR, 2006, 12 (02): : CR75 - CR80
  • [7] A prospective study of 5 years of GH replacement therapy in GH-deficient adults:: Sustained effects on body composition, bone mass, and metabolic indices
    Götherström, G
    Svensson, J
    Koranyi, J
    Alpsten, M
    Bosæus, I
    Bengtsson, BÅ
    Johannsson, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10): : 4657 - 4665
  • [8] Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults
    Barbosa, Edna J. L.
    Koranyi, Josef
    Filipsson, Helena
    Bengtsson, Bengt-Ake
    Boguszewski, Cesar Luiz
    Johannsson, Gudmundur
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (05) : 869 - 878
  • [9] Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy
    Barbosa, Edna J. L.
    Glad, Camilla A. M.
    Nilsson, Anna G.
    Nystrom, Helena Filipsson
    Gotherstrom, Galina
    Svensson, Per-Arne
    Vinotti, Isabela
    Bengtsson, Bengt-Ake
    Nilsson, Staffan
    Boguszewski, Cesar Luiz
    Johannsson, Gudmundur
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (03) : 353 - 362
  • [10] One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults
    Boguszewski, CL
    Meister, MHF
    Zaninelli, DCT
    Radominski, RB
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (01) : 67 - 75